Storia in 3 fonti

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

7 deaths and over 100 serious adverse events reported to FDA after treatment with Vykat XR

Raccontata da

medpagetoday.com

endpoints.news

healio.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 g fa

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

7 deaths and over 100 serious adverse events reported to FDA after treatment with Vykat XR

originale

endpoints.news1 g fa

Four questions on new safety warnings for Neurocrine’s Vykat XR

The treatment has been linked to seven deaths, largely due to heart or respiratory problems. It has also been associated with over 100 serious adverse events in Prader-Willi patients, raising safety and sales concerns.

Leggi questa versione → originale

Timeline cronologica

mercoledì 12 agosto 2026·medpagetoday.com
Experts Flag Potential Safety Concerns in New Prader-Willi Drug
7 deaths and over 100 serious adverse events reported to FDA after treatment with Vykat XR
mercoledì 12 agosto 2026·endpoints.news
Four questions on new safety warnings for Neurocrine’s Vykat XR
The treatment has been linked to seven deaths, largely due to heart or respiratory problems. It has also been associated with over 100 serious adverse events in Prader-Willi…

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

Confronto fonti

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

Four questions on new safety warnings for Neurocrine’s Vykat XR

Timeline cronologica

Experts Flag Potential Safety Concerns in New Prader-Willi Drug

Four questions on new safety warnings for Neurocrine’s Vykat XR

Prader-Willi syndrome groups call attention to possible safety risks with Vykat XR

Prader-Willi syndrome groups call attention to possible safety risks with Vykat XR